TGFB1 and cardiac hypertrophy: Moreover, blockade of the RAS with an angiotensin-converting-enzyme inhibitor (ACE I), Enalapril, significantly attenuated the UUO-induced cardiac hypertrophy and fibrosis and down-regulated TGF-β signaling.